EXPRESSION PATTERN OF THE ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE ALCAM/CD166 AS A DIAGNOSTIC AND PROGNOSTIC MARKER IN ENDOMETRIAL CANCER

被引：0
|
作者：
Briesel, J. [1 ,2 ]
Doeleke, F. [3 ]
Milde-Langosch, K. [4 ]
Sajin, M. [5 ]
Bamberger, A. M. [3 ]
机构：
[1] Univ Leeds, Dept Pathol & Tumor Biol, Leeds LS2 9JT, W Yorkshire, England
[2] Ernst Moritz Arndt Univ Greifswald, Dept Obstet & Gynaecol, D-17487 Greifswald, Germany
[3] Univ Clin, Sect Endocrinol & Metab Ageing, Hamburg, Germany
[4] Univ Clin, Dept Gynaecol, Hamburg, Germany
[5] Univ Bucharest, Dept Morphopathol, Bucharest, Romania
来源：
ANTICANCER RESEARCH | 2008年 / 28卷 / 6B期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
39
引用
收藏
页码：4030 / 4030
页数：1
相关论文
共 50 条
  • [41] Glycosylation-dependent binding of galectin-8 to activated leukocyte cell adhesion molecule (ALCAM/CD166) promotes its surface segregation on breast cancer cells
    Fernandez, Marisa M.
    Ferragut, Fatima
    Cardenas Delgado, Victor M.
    Bracalente, Candelaria
    Bravo, Alicia I.
    Cagnoni, Alejandro J.
    Nunez, Myriam
    Morosi, Luciano G.
    Quinta, Hector R.
    Espelt, Maria V.
    Troncoso, Maria F.
    Wolfenstein-Todel, Carlota
    Marino, Karina V.
    Malchiodi, Emilio L.
    Rabinovich, Gabriel A.
    Elola, Maria T.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2016, 1860 (10): : 2255 - 2268
  • [42] Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
    Kahlert, C.
    Weber, H.
    Mogler, C.
    Bergmann, F.
    Schirmacher, P.
    Kenngott, H. G.
    Matterne, U.
    Mollberg, N.
    Rahbari, N. N.
    Hinz, U.
    Koch, M.
    Aigner, M.
    Weitz, J.
    BRITISH JOURNAL OF CANCER, 2009, 101 (03) : 457 - 464
  • [43] Activated Leucocyte Cell Adhesion Molecule (CD166): A Biomarker in Diagnosis and Prognosis of Breast Cancer
    Hemalatha, Vemareddy
    Dev, Bhawna
    Rani, N. Vanitha
    Rajanandh, M. G.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2023, 17 (01) : XE1 - XE6
  • [44] ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE (ALCAM) IN DISTANT METASTASIS OF CANCER
    Sanders, Andrew J.
    Owen, Sioned
    Ye, Lin
    Mason, Malcolm D.
    Jiang, Wen G.
    ANTICANCER RESEARCH, 2015, 35 (07) : 4361 - 4361
  • [45] Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
    C Kahlert
    H Weber
    C Mogler
    F Bergmann
    P Schirmacher
    H G Kenngott
    U Matterne
    N Mollberg
    N N Rahbari
    U Hinz
    M Koch
    M Aigner
    J Weitz
    British Journal of Cancer, 2009, 101 : 457 - 464
  • [46] ALCAM, ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE, IN CLINICAL GASTRIC CANCER
    Yang, Yiming
    Sanders, Andrew J.
    Ji, Jiafu
    Ji, Ke
    Jia, Shuqin
    Jiang, Wen G.
    GUT, 2021, 70 : A141 - A141
  • [47] Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients
    Donizy, Piotr
    Zietek, Marcin
    Halon, Agnieszka
    Leskiewicz, Marek
    Kozyra, Cyprian
    Matkowski, Rafal
    DIAGNOSTIC PATHOLOGY, 2015, 10
  • [48] Prognostic Significance of Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Association with Promoter Methylation of the ALCAM Gene in Breast Cancer
    Jeong, Young Ju
    Oh, Hoon Kyu
    Park, Sung Hwan
    Bong, Jin Gu
    MOLECULES, 2018, 23 (01):
  • [49] Expression of ALCAM/CD166 and related proteins in breast cancer: tissue and cell lines
    不详
    BREAST, 2005, 14 : S17 - S17
  • [50] Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients
    Piotr Donizy
    Marcin Zietek
    Agnieszka Halon
    Marek Leskiewicz
    Cyprian Kozyra
    Rafal Matkowski
    Diagnostic Pathology, 10
12345